Oxidized LDL Mediated Upregulation of ADAMTS-4 in Monocytes/Macrophages Involves The ROS-NFκB Pathway
preprint
OA: closed
CC-BY-4.0
Abstract
Abstract ADAMTS-4 is a protease enzyme which involves in vascular remodeling and atherosclerosis. It was found to be upregulated in macrophages seen in atherosclerotic lesions. The aim of this study was to investigate the expression and regulation of ADAMTS-4 in oxLDL induced human monocytes/macrophages system. PBMCs isolated from human blood(hPBMCs), treated with oxLDL (50μg/ml) were used as the model system for the study. mRNA and protein expressions were studied by qRT-PCR, ELISA, and western blot analysis. ROS production and cell viability were determined by fluorescence imaging and MTT assay respectively. In the presence of oxLDL, monocytes get differentiated into macrophages, which were confirmed by the increased expression of CD-36, b- D glucuronidase activity and by the morphological changes. OxLDL increased the mRNA and protein expression of ADAMTS-4 and TIMP-3 in monocytes/ macrophages. A significant increase in the mRNA and protein expression of TNF-α was also observed in oxLDL treated cells compared to untreated control. In the presence of NAC, the ROS scavenger, the production of NFκB and ADAMTS-4 was decreased significantly. Our study suggests that oxLDL significantly upregulated the expression of ADAMTS-4 in the monocyte/macrophage system. OxLDL mediated upregulation of ADAMTS-4 in hPBMCs involves TNF-α and ROS- NFκB pathway.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0